GERON CORP Increase (Decrease) in Other Operating Assets
GERON CORP (GERN) reported Increase (Decrease) in Other Operating Assets of -$89.00 thousand for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2018-05-10
- GERON CORP increase (decrease) in other operating assets for the quarter ending 2018-03-31 was -$89.00K, a 101.48% decline year-over-year.
- GERON CORP increase (decrease) in other operating assets for the quarter ending 2017-03-31 was $6.00M.
- GERON CORP increase (decrease) in other operating assets for the quarter ending 2015-09-30 was $149.00K, a 129.23% increase year-over-year.
- GERON CORP increase (decrease) in other operating assets for the quarter ending 2015-06-30 was $126.00K.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 9 month |
|---|---|---|---|
| 2018-03-31 | -$89.00K 10-Q · filed 2018-05-10 | ||
| 2017-03-31 | $6.00M 10-Q · filed 2018-05-10 | ||
| 2015-09-30 | $149.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $275.00K derived: sum of 2 quarters · filed 2015-11-05 | $370.00K 10-Q · filed 2015-11-05 |
| 2015-06-30 | $126.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $221.00K 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $95.00K 10-Q · filed 2015-05-07 | ||
| 2014-09-30 | $65.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | -$162.00K derived: sum of 2 quarters · filed 2015-11-05 | $484.00K 10-Q · filed 2015-11-05 |
| 2014-06-30 | -$227.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $419.00K 10-Q · filed 2015-08-05 | |
| 2014-03-31 | $646.00K 10-Q · filed 2015-05-07 | ||
| 2013-09-30 | $344.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05 | -$559.00K derived: sum of 2 quarters · filed 2014-11-05 | -$904.00K 10-Q · filed 2014-11-05 |
| 2013-06-30 | -$903.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | -$1.25M 10-Q · filed 2014-08-11 | |
| 2013-03-31 | -$345.00K 10-Q · filed 2014-05-01 | ||
| 2012-09-30 | -$77.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | -$557.00K derived: sum of 2 quarters · filed 2013-11-07 | -$1.94M 10-Q · filed 2013-11-07 |
| 2012-06-30 | -$480.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | -$1.86M 10-Q · filed 2013-08-08 | |
| 2012-03-31 | -$1.38M 10-Q · filed 2013-05-03 | ||
| 2011-09-30 | -$312.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | -$1.40M derived: sum of 2 quarters · filed 2012-11-02 | -$3.56M 10-Q · filed 2012-11-02 |
| 2011-06-30 | -$1.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-03 | -$3.25M 10-Q · filed 2012-08-03 | |
| 2011-03-31 | -$2.16M 10-Q · filed 2012-05-07 | ||
| 2010-09-30 | -$1.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | -$3.78M 10-Q · filed 2011-11-03 | |
| 2010-06-30 | -$2.20M 10-Q · filed 2011-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B |